Filing Details

Accession Number:
0001209191-18-064285
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-28 12:36:19
Reporting Period:
2018-12-21
Accepted Time:
2018-12-28 12:36:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887151 Capstone Therapeutics Corp. CAPS Pharmaceutical Preparations (2834) 860585310
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201333 S Neil Subin 3300 South Dixie Highway
Suite 1-365
West Palm Beach FL 33405
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-21 206,000 $0.05 2,708,484 No 4 S Indirect By MBM - Trust A-4
Common Stock Acquisiton 2018-12-21 103,000 $0.05 727,100 No 4 P Indirect By LIMFAM LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By MBM - Trust A-4
No 4 P Indirect By LIMFAM LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,914,484 Indirect By LIM III - Trust A-4
Common Stock 641,218 Indirect By Trust C - Lloyd I. Miller
Common Stock 90,344 Indirect By Trust D - Lloyd I. Miller
Common Stock 472,792 Indirect By Milfam II L.P.
Footnotes
  1. The reported transaction involved a sale of a total of 206,000 shares of Capstone Therapeutics Corp. ("Capstone") common stock by MBM -Trust A-4, which were acquired by LIMFAM LLC and another private purchaser at a privately negotiated price equal to $0.052 per share. The reporting personmay be deemed to have voting and dispositive control over shares held by MBM - Trust A-4 and LIMFAM LLC.
  2. The reporting person believes that the reported transaction constitutes a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Act pursuant to Rule 16a-13.
  3. Except for possessing voting and dispositive power, the reporting person disclaims any other beneficial ownership of, and specifically any pecuniary interest in, the securities reported herein. This filing is not, and shall not be deemed, an admission (and the reporting person expressly disclaims) that the reporting person is, for purposes of Rule 16a-1(a)(2) under Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any equity securities covered by this filing.
  4. The reporting person succeeded to the position of President and Manager of MILFAM LLC, which serves as manager, general partner, or investment advisor of a number of entities formerly managed or advised by the late Lloyd I. Miller, III. The reporting person also serves as trustee of a number of Miller family trusts.